Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043)

Detalles Bibliográficos
Autores principales: Brilland, Benoit, Wacrenier, Samuel, Henry, Nicolas, Guibert, Fanny, Piccoli, Giorgina Barbara, Augusto, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589689/
https://www.ncbi.nlm.nih.gov/pubmed/34805646
http://dx.doi.org/10.1016/j.ekir.2021.08.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589689/
https://www.ncbi.nlm.nih.gov/pubmed/34805646
http://dx.doi.org/10.1016/j.ekir.2021.08.026

Ejemplares similares